These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 872557)

  • 21. Extrapyramidal side effects with lithium treatment.
    Kane J; Rifkin A; Quitkin F; Klein DF
    Am J Psychiatry; 1978 Jul; 135(7):851-3. PubMed ID: 665801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
    Meszaros K; Lenzinger E; Hornik K; Schönbeck G; Hatzinger R; Langer G; Sieghart W; Aschauer HN
    Neuropsychobiology; 1997; 36(2):69-72. PubMed ID: 9267855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate.
    Gelenberg AJ; Doller JC; Schooler NR; Mieske M; Severe J; Mandel MR
    Am J Psychiatry; 1979 Feb; 136(2):217-9. PubMed ID: 367182
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of drugs in schizophrenia. Discussion on assessment of drug-induced extrapyramidal reactions.
    McClelland HA
    Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):401-3. PubMed ID: 9966
    [No Abstract]   [Full Text] [Related]  

  • 25. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models.
    Casey DE
    Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821
    [No Abstract]   [Full Text] [Related]  

  • 26. Risperidone and olanzapine versus another first generation antipsychotic in patients with schizophrenia inadequately responsive to first generation antipsychotics.
    Chen JJ; Chan HY; Chen CH; Gau SS; Hwu HG
    Pharmacopsychiatry; 2012 Mar; 45(2):64-71. PubMed ID: 22086749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The use of nifedipine as a corrector of extrapyramidal side-effects of classical neuroleptics].
    Popov MIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(6):28-33. PubMed ID: 18577931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychological factors in susceptibility to drug-induced extrapyramidal symptoms.
    Levinson P; Malen R; Hogben G; Smith H
    Am J Psychiatry; 1978 Nov; 135(11):1375-6. PubMed ID: 707640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the effects of oxypertine and trifluoperazine in withdrawn schizophrenics.
    Hunt PV
    Br J Psychiatry; 1967 Dec; 113(505):1419-24. PubMed ID: 4865294
    [No Abstract]   [Full Text] [Related]  

  • 30. A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients.
    Gross HS
    Curr Ther Res Clin Exp; 1974 Jul; 16(7):696-705. PubMed ID: 4210459
    [No Abstract]   [Full Text] [Related]  

  • 31. The purely neuroleptic effects and its relation to the "neuroleptic threshold".
    Haase HJ
    Acta Psychiatr Belg; 1978; 78(1):19-36. PubMed ID: 645405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind comparison of loxapine succinate and trifluoperazine in newly admitted schizophrenic patients.
    Simpson GM; Cuculic Z
    J Clin Pharmacol; 1976 Jan; 16(1):60-5. PubMed ID: 1107360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative short-term evaluation of penfluridol and trifluoperazine in chronic schizophrenia.
    Khorana AB; Patel Y
    Indian J Physiol Pharmacol; 1988; 32(4):293-8. PubMed ID: 3063660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A twelve month comparison of penfluridol and trifluoperazine in chronic schizophrenic outpatients.
    Donlon PT; Meyer JE
    J Clin Psychiatry; 1978 Jun; 39(6):582-3, 686-8. PubMed ID: 350861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neuroleptic hypothesis: study of the covariation of extrapyramidal and therapeutic drug effects.
    Alpert M; Diamond F; Weisenfreund J; Taleporos E; Friedhoff AJ
    Br J Psychiatry; 1978 Aug; 133():169-75. PubMed ID: 354734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, I.
    Amin MM; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1977 Jul; 13(3):15-7. PubMed ID: 329323
    [No Abstract]   [Full Text] [Related]  

  • 37. A standard- (trifluoperazine) controlled clinical study with clomacran in newly admitted schizophrenic patients.
    Pecknold JC; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1977 Jul; 13(3):14-5. PubMed ID: 329322
    [No Abstract]   [Full Text] [Related]  

  • 38. Physostigmine effects on phenothiazine-induced extrapyramidal reactions.
    Ambani LM; Van Woert MH; Bowers MB
    Arch Neurol; 1973 Dec; 29(6):444-6. PubMed ID: 4759422
    [No Abstract]   [Full Text] [Related]  

  • 39. Trifluperidol and trifluoperazine in acute schizophrenic patients.
    Sugerman AA; Williams BH
    J New Drugs; 1965; 5(5):318-26. PubMed ID: 5329635
    [No Abstract]   [Full Text] [Related]  

  • 40. A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, II.
    Vergara L; Amin MM; Ban TA
    Psychopharmacol Bull; 1977 Jul; 13(3):17-9. PubMed ID: 329324
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.